GlassScriptPhysician profile
Mhammad Gaith S Semrin
NPI 1194787358
$1,233.26
in general payments reported to CMS, 2019-2025
16 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2021: $18.71 · 2022: $67.86 · 2023: $104 · 2024: $484 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $208.66 | 2022-2024 | Dupixent |
| Genzyme Corporation | $205.50 | 2024-2025 | |
| Qol Medical, LLC | $196.79 | 2019-2023 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $168.47 | 2023-2025 | Gattex, Eohilia, Vpriv |
| Janssen Scientific Affairs, LLC | $136.11 | 2025 | Stelara, Tremfya |
| Mirum Pharmaceuticals, INC. | $81.43 | 2022-2024 | Livmarli, Cholbam |
| Alcresta Therapeutics, INC. | $45.71 | 2023-2024 | Relizorb |
| Acadia Pharmaceuticals INC | $26.55 | 2023 | Daybue |
| Aimmune Therapeutics, INC. | $24.50 | 2025 | Zenpep |
| Mauna Kea Technologies, INC. | $23.86 | 2025 | |
| Intrabio INC | $22.66 | 2025 | Aqneursa |
| Eton Pharmaceuticals, INC. | $22.54 | 2025 | Galzin, Nitisinone, Betaine Anhydrous |
| Nestle Healthcare Nutrition INC. | $22.02 | 2022 | |
| Ucb, INC. | $18.71 | 2021 | |
| Abbvie INC. | $15.43 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $14.32 | 2024 | Bylvay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mhammad Gaith Semrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.